Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Med Inform Assoc ; 30(10): 1693-1700, 2023 09 25.
Article in English | MEDLINE | ID: mdl-37414539

ABSTRACT

OBJECTIVE: Researchers at New York University (NYU) Grossman School of Medicine contacted the Health Sciences Library for help with locating large datasets for reuse. In response, the library developed and maintained the NYU Data Catalog, a public-facing data catalog that has supported not only faculty acquisition of data but also the dissemination of the products of their research in various ways. MATERIALS AND METHODS: The current NYU Data Catalog is built upon the Symfony framework with a tailored metadata schema reflecting the scope of faculty research areas. The project team curates new resources, including datasets and supporting software code, and conducts quarterly and annual evaluations to assess user interactions with the NYU Data Catalog and opportunities for growth. RESULTS: Since its launch in 2015, the NYU Data Catalog underwent a number of changes prompted by an increase in the disciplines represented by faculty contributors. The catalog has also utilized faculty feedback to enhance support of data reuse and researcher collaboration through alterations to its schema, layout, and visibility of records. DISCUSSION: These findings demonstrate the flexibility of data catalogs as a platform for enabling the discovery of disparate sources of data. While not a repository, the NYU Data Catalog is well-positioned to support mandates for data sharing from study sponsors and publishers. CONCLUSION: The NYU Data Catalog makes the most of the data that researchers share and can be harnessed as a modular and adaptable platform to promote data sharing as a cultural practice.


Subject(s)
Medicine , Software , Humans , New York , Universities
2.
Annu Rev Microbiol ; 77: 541-560, 2023 09 15.
Article in English | MEDLINE | ID: mdl-37406344

ABSTRACT

Apicomplexan parasites constitute more than 6,000 species infecting a wide range of hosts. These include important pathogens such as those causing malaria and toxoplasmosis. Their evolutionary emergence coincided with the dawn of animals. Mitochondrial genomes of apicomplexan parasites have undergone dramatic reduction in their coding capacity, with genes for only three proteins and ribosomal RNA genes present in scrambled fragments originating from both strands. Different branches of the apicomplexans have undergone rearrangements of these genes, with Toxoplasma having massive variations in gene arrangements spread over multiple copies. The vast evolutionary distance between the parasite and the host mitochondria has been exploited for the development of antiparasitic drugs, especially those used to treat malaria, wherein inhibition of the parasite mitochondrial respiratory chain is selectively targeted with little toxicity to the host mitochondria. We describe additional unique characteristics of the parasite mitochondria that are being investigated and provide greater insights into these deep-branching eukaryotic pathogens.


Subject(s)
Malaria , Toxoplasma , Animals , Mitochondria/genetics , Mitochondria/metabolism , Toxoplasma/metabolism , Biological Evolution
3.
PLoS One ; 17(8): e0273357, 2022.
Article in English | MEDLINE | ID: mdl-35984838

ABSTRACT

Despite ongoing efforts to control malaria infection, progress in lowering the number of deaths and infections appears to have stalled. The continued high incidence of malaria infection and mortality is in part due to emergence of parasites resistant to frontline antimalarials. This highlights the need for continued identification of novel protein drug targets. Mitochondrial functions in Plasmodium falciparum, the deadliest species of human malaria parasite, are targets of validated antimalarials including atovaquone and proguanil (Malarone). Thus, there has been great interest in identifying other essential mitochondrial proteins as candidates for novel drug targets. Garnering an increased understanding of the proteomic landscape inside the P. falciparum mitochondrion will also allow us to learn about the basic biology housed within this unique organelle. We employed a proximity biotinylation technique and mass spectrometry to identify novel P. falciparum proteins putatively targeted to the mitochondrion. We fused the leader sequence of a mitochondrially targeted chaperone, Hsp60, to the promiscuous biotin ligase TurboID. Through these experiments, we generated a list of 122 "putative mitochondrial" proteins. To verify whether these proteins were indeed mitochondrial, we chose five candidate proteins of interest for localization studies using ectopic expression and tagging of each full-length protein. This allowed us to localize four candidate proteins of unknown function to the mitochondrion, three of which have previously been assessed to be essential. We suggest that phenotypic characterization of these and other proteins from this list of 122 could be fruitful in understanding the basic mitochondrial biology of these parasites and aid antimalarial drug discovery efforts.


Subject(s)
Antimalarials , Malaria, Falciparum , Malaria , Antimalarials/therapeutic use , Atovaquone/therapeutic use , Biotinylation , Drug Combinations , Humans , Malaria/parasitology , Malaria, Falciparum/drug therapy , Malaria, Falciparum/parasitology , Plasmodium falciparum/genetics , Plasmodium falciparum/metabolism , Proguanil/therapeutic use , Proteomics
4.
J Immunol ; 196(10): 4100-9, 2016 05 15.
Article in English | MEDLINE | ID: mdl-27076677

ABSTRACT

During visceral leishmaniasis (VL), Th1-based inflammation is induced to control intracellular parasites. Inflammation-based pathology was shown to be dampened by IL-10 and eventual programmed death 1-mediated T cell exhaustion. Cell type(s) responsible for the initiation of T cell-produced IL-10 during VL are unknown. CD19(+), CD5(-), CD1d(-), IgD(hi) regulatory B cells from healthy controls produced IL-10 in the absence of infection or stimulation, in contrast to IgD(lo/neg) B cells. IgD(hi) B cells may have a de novo versus induced regulatory program. The population of IgD(hi) B cells increased 3-fold as VL progressed. B cells from VL dogs were necessary and sufficient to suppress Th1 cell effector function. IgD(hi) B cells induced IL-10 production by T cells and IgD(lo) B cells. Blockage of B cell-specific PD-L1 restored Th1 responses. IgD(hi) regulatory B cells represent a novel regulatory B cell that may precipitate T cell exhaustion during VL.


Subject(s)
Antigens, Protozoan/immunology , B-Lymphocytes, Regulatory/immunology , B7-H1 Antigen/metabolism , Interleukin-10/metabolism , Leishmania infantum/immunology , Leishmaniasis, Visceral/immunology , Protozoan Proteins/immunology , Th1 Cells/immunology , Animals , Antibodies, Blocking/metabolism , Antibodies, Protozoan/metabolism , B-Lymphocytes, Regulatory/parasitology , B7-H1 Antigen/immunology , Cells, Cultured , Disease Progression , Dogs , Female , Humans , Immune Tolerance , Immunoglobulin D/metabolism , Male , Th1 Cells/parasitology
5.
Am J Pathol ; 185(8): 2105-17, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26079813

ABSTRACT

Chronic kidney disease is a major contributor to human and companion animal morbidity and mortality. Renal complications are sequelae of canine and human visceral leishmaniasis (VL). Despite the high incidence of infection-mediated glomerulonephritis, little is known about pathogenesis of VL-associated renal disease. Leishmania infantum-infected dogs are a naturally occurring model of VL-associated glomerulonephritis. Membranoproliferative glomerulonephritis type I [24 of 25 (96%)], with interstitial lymphoplasmacytic nephritis [23 of 25 (92%)], and glomerular and interstitial fibrosis [12 of 25 (48%)] were predominant lesions. An ultrastructural evaluation of glomeruli from animals with VL identified mesangial cell proliferation and interposition. Immunohistochemistry demonstrated significant Leishmania antigen, IgG, and C3b deposition in VL dog glomeruli. Asymptomatic and symptomatic dogs had increased glomerular nucleotide-binding domain leucine-rich repeat-containing-like receptor family, pyrin domain containing 3 and autophagosome-associated microtubule-associated protein 1 light chain 3 associated with glomerular lesion severity. Transcriptional analyses from symptomatic dogs confirmed induction of autophagy and inflammasome genes within glomeruli and tubules. On the basis of temporal VL staging, glomerulonephritis was initiated by IgG and complement deposition. This deposition preceded presence of nucleotide-binding domain leucine-rich repeat-containing-like receptor family, pyrin domain containing 3-associated inflammasomes and increased light chain 3 puncta indicative of autophagosomes in glomeruli from dogs with clinical VL and renal failure. These findings indicate potential roles for inflammasome complexes in glomerular damage during VL and autophagy in ensuing cellular responses.


Subject(s)
Autophagy/physiology , Carrier Proteins/metabolism , Glomerulonephritis/veterinary , Inflammasomes/metabolism , Leishmania infantum , Leishmaniasis, Visceral/veterinary , Animals , Dogs , Glomerulonephritis/metabolism , Glomerulonephritis/parasitology , Kidney Glomerulus/metabolism , Kidney Glomerulus/parasitology , Kidney Glomerulus/pathology , Leishmaniasis, Visceral/complications , Leishmaniasis, Visceral/metabolism
6.
Food Chem Toxicol ; 45(7): 1277-92, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17329002

ABSTRACT

59122 is a transgenic maize line containing event DAS-59122-7 that expresses the corn rootworm (CRW) specific pesticidal Cry34Ab1 and Cry35Ab1 proteins from Bacillus thuringiensis (Bt) Berliner strain PS149B1 and the phosphinothricin-N-acetyltransferase (PAT) protein from Streptomyces viridochromogenes for tolerance to the herbicidal ingredient glufosinate-ammonium. For the current study, 59122 maize grain, non-transgenic near-isogenic maize grain (091), and a commercially available non-transgenic reference maize grain (33R77) were grown under conditions simulating commercial farming practices. Adult Sprague-Dawley rats (12/sex/group) were fed diets formulated with 35% maize grain from either 59122, 091, or 33R77, or one of two separate lots of commercially available rodent chow prepared with commercially available corn (35%) in accordance with the standards of Purina Mills Labdiet 5002 for approximately 90 days. All diets possessed similar nutritional and contaminant profiles. The transgenic proteins were detected only in diets prepared with 59122 maize grain and were stable over the course of the study. Compared to control groups, no adverse diet-related differences were observed in rats fed diets formulated with 59122 maize grain with respect to body weight/gain, food consumption/efficiency, clinical signs of toxicity, mortality, ophthalmology, neurobehavioral (FOB and motor activity) assessments, clinical pathology (hematology, clinical chemistry, coagulation, and urinalysis), and pathology (organ weights and gross and microscopic pathology). Results from this study indicate that 59122 maize grain is nutritionally equivalent to and as safe as conventional maize grain.


Subject(s)
Bacterial Proteins/genetics , Bacterial Toxins/genetics , Endotoxins/genetics , Hemolysin Proteins/genetics , Insecticides , Plants, Genetically Modified/toxicity , Toxicity Tests/methods , Zea mays/genetics , Animals , Bacillus thuringiensis Toxins , Behavior, Animal/drug effects , Diet , Eating/drug effects , Energy Metabolism/drug effects , Female , Hematologic Tests , Longevity/drug effects , Male , Organ Size/drug effects , Pest Control, Biological , Plants, Genetically Modified/genetics , Rats , Rats, Sprague-Dawley , Weight Gain/drug effects
7.
Food Chem Toxicol ; 45(4): 551-62, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17097206

ABSTRACT

Maize line 1507, containing event DAS-Ø15Ø7-1 (1507), is a genetically modified (GM) maize plant that expresses the cry1F gene from Bacillus thuringiensis (Bt) sbsp. aizawai and the phosphinothricin-N-acetyltransferase (pat) gene from Streptomyces viridochromogenes throughout the plant including in the grain expression of the Cry1F protein confers in planta resistance to the European corn borer (ECB; Ostrinia nubilalis Hübner: Crambidae) and other lepidopteran pests. Expression of the PAT protein confers tolerance to the herbicidal active ingredient glufosinate-ammonium. The current study evaluated the nutritional performance of rats fed diets containing 1507 maize grain in a subchronic rodent feeding study. The grains in this study, 1507, its near-isogenic control (33P66), and a non-GM commercial hybrid (33J56) contained similar amounts of proximates, amino acids, minerals, anti-nutrients, and secondary metabolites. The subchronic feeding study compared standard toxicology response variables in rats fed diets containing 1507 maize grain with those in rats fed diets containing non-GM maize grains. All diets were prepared according to the specifications of PMI Nutrition International, LLC Certified Rodent LabDiet 5002 (PMI) 5002). Diets were fed ad libitum to Sprague-Dawley rats for approximately 90 days. In-life response variables included indicators of dietary performance and weekly evaluations for clinical signs of toxicity. No toxicologically significant differences were observed in the nutritional performance variables, clinical and neurobehavioral signs, ophthalmology, clinical pathology (hematology, clinical chemistry, coagulation, and urinalysis), organ weights, and gross and microscopic pathology between any pair of treatment groups. These results demonstrate that 1507 maize grain is as safe and as nutritious as non-GM maize grain.


Subject(s)
Bacterial Proteins/genetics , Bacterial Toxins/genetics , Endotoxins/genetics , Hemolysin Proteins/genetics , Plants, Genetically Modified/toxicity , Zea mays/toxicity , Alkaline Phosphatase/blood , Animals , Bacillus thuringiensis Toxins , Body Weight , Eating , Female , Male , Motor Activity , Organ Size , Rats , Rats, Sprague-Dawley , Zea mays/genetics
8.
Ann N Y Acad Sci ; 964: 117-27, 2002 May.
Article in English | MEDLINE | ID: mdl-12023199

ABSTRACT

Three case studies are described; each represents a specific application of the IFBC/ILSI decision tree as prescribed by Metcalfe et al. to assess the allergenic potential of foods derived from genetically engineered crop plants. The case studies include high methionine soybean, high oleic soybean and Herculex TM 1 Insect Protected Maize, the results of which support/validate the use of the IFBC/ILSI decision tree for the prescribed applications.


Subject(s)
Allergens/chemistry , Allergens/immunology , Crops, Agricultural/genetics , Genetic Engineering , Blotting, Western , Data Interpretation, Statistical , Decision Trees , Humans , Oleic Acid/metabolism , Glycine max/genetics , Glycine max/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...